StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Becton Dickinson (BDX) PT Lowered to $265 at Morgan Stanley
November 7, 2018 7:54 AM
Morgan Stanley analyst David Lewis ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst PT Change
Next Articles
Becton Dickinson (BDX) Highlights Clinical Trial Data for LUTONIX 014 Drug-Coated Balloon Below-the-Knee IDE
November 7, 2018 1:14 PM